Immunomagnetic negative selection of peripheral blood progenitor cells (PBPC) from patients with hematological malignancies: Purging efficacy, hematopoietic cell recovery, engraftment.

被引：0
|
作者：
Hansz, J [1 ]
Sawinski, K [1 ]
Kozlowska-Skrzypczak, M [1 ]
机构：
[1] Univ Med Sci Poznan, Dept Hematol, Poznan, Poland
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
373
引用
收藏
页码：S106 / S106
页数：1
相关论文
共 50 条
  • [41] Isolation of Hematopoietic Progenitor Cells from Peripheral Blood of Sickle Cell Disease Patients: A Feasibility Study
    Bruns, C.
    Perumbeti, A.
    Temples, T.
    Grassman, E.
    Cancelas, J. A.
    Malik, P.
    Leemhuis, T.
    TRANSFUSION, 2010, 50 : 216A - 216A
  • [42] Autografting with Philadelphia (PH) chromosome-negative or partially negative peripheral blood progenitor cells (PBPC) in patients with chronic myelogenous leukemia
    Lerma, E
    Benvenuto, F
    Podesta, M
    Pitto, A
    Vassallo, F
    Soracco, M
    Prencipe, E
    Gatti, AM
    Ghio, R
    Frassoni, F
    Carella, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 325 - 325
  • [43] Positive selection and transplantation of peripheral CD34+ progenitor cells: Feasibility and purging efficacy in pediatric patients with neuroblastoma
    Handgretinger, R
    Greil, J
    Schurmann, U
    Lang, P
    GonzalezRamella, O
    Schmidt, I
    Fuhrer, R
    Niethammer, D
    Klingebiel, T
    JOURNAL OF HEMATOTHERAPY, 1997, 6 (03): : 235 - 242
  • [44] Efficacy of increased dose G-CSF in poorly mobilizing autologous peripheral blood progenitor cell (PBPC) patients
    Aysola, A
    Donnenberg, AD
    Buchbarker, D
    Hammert, L
    Kiss, JE
    TRANSFUSION, 1999, 39 (10) : 102S - 102S
  • [45] Combined positive/negative purging and transplantation of peripheral blood progenitor cell autografts in breast cancer patients:: a pilot study
    Mapara, MY
    Körner, IJ
    Lentzsch, S
    Krahl, D
    Reichardt, P
    Dörken, B
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (01) : 169 - 175
  • [46] Autografting with Philadelphia (PH) chromosome-negative or partially negative peripheral blood progenitor cells (PBPC) in patients with chronic myelogenous leukemia.
    Prencipe, E
    Lerma, E
    Benvenuto, F
    Podesta, M
    Pitto, A
    Vassallo, F
    Soracco, M
    Frassoni, F
    Gatti, AM
    Ghio, R
    Carella, AM
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 94 - 94
  • [47] Steady-state mobilization of peripheral blood progenitor cells by cytokines alone in patients with solid tumors or hematological malignancies
    Kröger, N
    Zeller, W
    Hassan, HT
    Krüger, W
    Renges, H
    Rüssmann, B
    Fuchs, N
    Rauhöft, C
    Gutensohn, K
    Löliger, C
    Erttmann, R
    Kühnl, P
    Zander, AR
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1999, 26 (02): : 85 - 90
  • [48] Serum-free ex vivo expansion of peripheral blood hematopoietic stem cells derived from patients with hematological malignancies.
    Yao, C.
    Kao, I.
    Chiou, T.
    Chen, P.
    Hwang, S.
    CYTOTHERAPY, 2006, 8
  • [49] Hematological and immunological recovery after high dose chemotherapy ((HDC) and reinfusion of cd34+selected peripheral blood progenitor cells (PBPC) in patients with breast cancer (BC)
    De Rosa, L
    Lalle, M
    Amodeo, R
    Armentano, C
    Blandino, F
    Marzetti, L
    Pandolfi, A
    Passa, AR
    Pescador, L
    Ruscio, C
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S296 - S296
  • [50] Hematopoietic side population (SP) cells are present in highly purified human CD34+cells from peripheral blood progenitor cells (PBPC).
    Josefsen, D
    Rusten, LS
    Stokke, T
    Smeland, EB
    Kvalheim, G
    BLOOD, 2001, 98 (11) : 124B - 124B
12345